Ethereal Jaunt
The Science Behind the Asset
RNA is a proven, precise active ingredient with an established safety profile. The RNAs designed by Ethereal Jaunt are endogenous — molecules that already exist in the human body, not foreign chemicals, antigens, or vaccines. RNA is already used as an active ingredient in consumer and cosmetic products.
Ethereal Jaunt's products enhance specific neurological pathways in designated brain regions. Target pathways include, for example, serotonin, oxytocin, vasopressin, beta-endorphin, and neuropeptide Y. Each product is engineered for pathway-level precision in the regions that govern the dimension of experience it addresses.
Proof of Concept
This chart depicts representative results from behavioral animal models, where RNA designed by Ethereal Jaunt to target the animal pathway induced rapid and sustained recovery of social bonding to baseline levels compared with deteriorating social behavior and aggression in untreated groups.
This effect was observed following a single dose of the active RNA. Animal experiments were approved by the National Ethics Committee for Experiments in Animals, and were conducted under careful supervision of the animals. The final formulation of EQ was not tested on animals.
Illustrative data based on trends observed in behavioral models of aggression during product development. Individual experiences may vary.
Founder
Dr. Ido Bachelet, PhD
Pharmacologist, entrepreneur, and pioneer in therapeutic and consumer RNA design. PhD from the Hebrew University, postdoctoral fellow at MIT and Harvard Medical School, at the lab of Prof. George Church. Founded multiple biotech companies with over $300M in total funding raised and served in C-level roles. H-index of 25, with over 30 patents.